Abstract Neurodegenerative diseases, such as Alzheimer’s disease, constitute a major socioeconomic burden. As clinical prevalence dramatically increases, the need for disease-modifying therapies is pressing. In this context, regenerative medicine are considered promising strategy treatment of these patients, due to low turnover neural tissues and extensive neurodegeneration. The transplant exog...